学术探索
学术期刊
新闻热点
数据分析
智能评审

Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers

被引：9
作者：
Berl, Tomas [1 ]
机构：
[1] Univ Colorado Hlth Sci, Div Nephrol, Denver, CO 80262 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2008年 / 23卷 / 08期
关键词：
D O I：
10.1093/ndt/gfn239
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：2443 / 2447
页数：5
相关论文
共 26 条
  • [1] Optimal dose of losartan for renoprotection in diabetic nephropathy
    Andersen, S
    Rossing, P
    Juhl, TR
    Deinum, J
    Parving, HH
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (08) : 1413 - 1418
  • [2] Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies
    Aranda, P
    Segura, J
    Ruilope, LM
    Aranda, FJ
    Frutos, MA
    López, V
    de Novales, EL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (06) : 1074 - 1079
  • [3] Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy
    Atkins, RC
    Briganti, EM
    Lewis, JB
    Hunsicker, LG
    Braden, G
    de Crespigny, PJC
    DeFerrari, G
    Drury, P
    Locatelli, F
    Wiegmann, TB
    Lewis, EJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) : 281 - 287
  • [4] Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
    Bianchi, S.
    Bigazzi, R.
    Campese, V. M.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (12) : 2116 - 2123
  • [5] Bidani A, 2006, AM J NEPHROL, V26, P632
  • [6] BURGESS E, 2007, J AM SOC NEPHROL, V18, pA57
  • [7] Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
    de Zeeuw, D
    Remuzzi, G
    Parving, HH
    Keane, WF
    Zhang, ZX
    Shahinfar, S
    Snapinn, S
    Cooper, MF
    Mitch, WE
    Brenner, BM
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (06) : 2309 - 2320
  • [8] Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes
    Epstein, Murray
    Williams, Gordon H.
    Weinberger, Myron
    Lewin, Andrew
    Krause, Scott
    Mukherjee, Robin
    Patni, Rajiv
    Beckerman, Bruce
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (05): : 940 - 951
  • [9] Angiotensin II receptor blockade - Is there truly a benefit of adding an ACE inhibitor?
    Forclaz, A
    Maillard, M
    Nussberger, J
    Brunner, HR
    Burnier, M
    [J]. HYPERTENSION, 2003, 41 (01) : 31 - 36
  • [10] Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus
    Hollenberg, Norman K.
    Parving, Hans-Henrik
    Viberti, Giancarlo
    Remuzzi, Giuseppe
    Ritter, Susan
    Zelenkofske, Steven
    Kandra, Albert
    Daley, William L.
    Rocha, Ricardo
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 (09) : 1921 - 1926
123